![]() |
|
|

*
USDA/HNRC Tufts University, Boston, MA,
University of Alabama at Birmingham, Birmingham, AL
| Overview |
|---|
|
|
|---|
| In vitro methods: iron case study |
|---|
|
|
|---|
The group cited in vitro iron bioavailability studies using a current
state-of-the-art technique involving cultured human Caco-2 cells as an
illustrative case study. Caco-2 cells are a human intestinal cell line
originally derived from a colon adenocarcinoma and have various
properties that make them suitable for studying cellular aspects of
iron metabolism and iron transport (2). Iron-dependent systems that
can be studied with this model include iron-dependent regulation of
the hereditary hemochromatosis gene, HFE, and of DMT1, a
proton-coupled iron transporter gene (3), and iron-dependent
ferritin synthesis (4). Investigators have developed in vitro
approaches, based either on radioactive iron uptake (5)
or
cellular ferritin synthesis (6) to estimate iron bioavailability from
food and recently, dietary supplements (7).
Using these techniques, the bioavailability of iron can be determined
from an enzyme digest after dialysis of the digest iron across a
low-molecular-weight cutoff membrane. Relative iron bioavailability is
estimated by measuring either Caco-2 cell iron uptake from
radioisotope-labeled digests (5,8) or cellular ferritin
synthesis (6)
using nonradioactive starting materials
usually in comparison to ferrous ascorbate.
The group acknowledged that one potential shortcoming of the
Caco-2 cell approach is that there has been no published work to
directly compare estimates of relative iron bioavailability determined
in the Caco-2 cell system with human iron absorption studies. However,
based on the results of a new study, Au and Reddy (9)
report a significant correlation (r = 0.92) between
iron uptake in Caco-2 cell from various food digests and human iron
absorption. Thus, although more validation studies are necessary,
especially with iron supplements, it seems that an in vitro approach
using Caco-2 cells is promising in predicting human iron
bioavailability.
Despite the obvious screening value of an in vitro system for predicting relative iron absorption, the Working Group concluded that human absorption studies will remain the gold standard for estimating human iron bioavailability.
| In vivo methods: folate case study |
|---|
|
|
|---|
In brief, both short-term and long-term studies have been used
to estimate folate bioavailability in humans. These in vivo studies
were based on the determination of folate content in blood or urine,
and the studies often combined the use of radioactive or stable
isotope-labeled oral folates. The Working Group delineated several
limitations and caveats associated with in vivo human folate
bioavailability studies including: Studies of relative
bioavailability should be performed by measuring the relative response
using a linear portion of the response curve irrespective of the
endpoint that is used to assess bioavailability. Often
in an attempt to keep the experimental test conditions physiological, a
small oral folate dose is used. This experimental approach only gives a
minimal rise in serum or urinary folate that is often difficult to
detect. Further, because there are large intersubject variations in the
postprandial folate response, the estimation of folate bioavailability
using these physiological doses of folate is difficult
(10)
. Moreover, information on the absolute
bioavailability (fractional absorption) of various forms of folate is
extremely scarce.
The use of isotopically labeled folates greatly increases the
sensitivity of measuring folate absorption and can provide an estimate
of fractional folate absorption when combined with an intravenous dose.
For example, Pfeiffer et al. (11)
reported that the
bioavailability of stable isotope-labeled folic acid
(pteroylglutamic acid) cooked into wheat flour-based foods was
8085% compared with that of an orally administered dose of stable
isotope-labeled folic acid alone in healthy adult subjects.
Likewise, Buchholz et al. (12)
reported that a small dose
of 14C-labeled folic acid was
90% absorbed in
healthy adult males. In the latter study, it was necessary to use
accelerator mass spectrometry to measure extremely small amounts of
radioactivity in blood, urine and feces. The estimation of folate
bioavailability using these isotope methods is promising.
The Working Group concluded that additional studies using these methods are likely to provide us with solid quantitative data of the fractional absorption of extrinsically labeled folates. Similar novel approaches to estimate bioavailability might be developed for other bioactive substances as well.
The Working Group also noted that a specific limitation confronting those attempting to evaluate folate bioavailability is the lack of readily available sensitive means to accurately assess folate status, which is often used in experiments as an endpoint for determining folate bioavailability.
| Research recommendations |
|---|
|
|
|---|
| In vitro methods |
|---|
|
|
|---|
| In vivo methods |
|---|
|
|
|---|
In vivo estimations of bioavailability in humans are the holy grail but can be quite expensive and may be seriously hampered by numerous technical or ethical considerations. Newer stable isotope and low enrichment 14C-based absorption methods are promising but may have limited potential to the measurement of bioavailability by the community at-large because of demanding analytical procedures or limitations in access to equipment. Thus, there will continue to be a need to develop reliable in vitro methods to screen the bioavailability of dietary supplements and rank the more promising formulations for additional direct studies in humans. However, the Working Group cautioned about the uncritical application of these surrogate techniques because these in vitro methods will need to be evaluated for efficacy on a case-by-case basis and it is highly unlikely that any particular experimental approach will suffice for all bioactive substances of interest.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
1. Miller D. D., Berner L. A. Is solubility in vitro a reliable predictor of iron bioavailability?. Biol. Trace Elem. Res. 1989;19:11-24[Medline]
2. Alvarez-Hernandez X., Nichols G. M., Glass J. Caco-2 cell line: a system for studying intestinal iron transport across epithelial cell monolayers. Biochim. Biophys. Acta 1991;1070:205-208[Medline]
3.
Han O., Fleet J. C., Wood R. J. Reciprocal regulation of HFE and Nramp2 gene expression by iron in human intestinal cells. J. Nutr. 1999;129:98-104
4. Alvarez-Hernandez X., Smith M., Glass J. Regulation of iron uptake and transport by transferrin in Caco-2 cells, an intestinal cell line. Biochim. Biophys. Acta 1994;1192:215-222[Medline]
5. Garcia M. N., Flowers C., Cook J. D. The Caco-2 cell culture system can be used as a model to study food iron availability. J. Nutr. 1996;126:251-258
6.
Glahn R. P., Lee O. A., Yeung A., Goldman M. I., Miller D. D. Caco-2 cell ferritin formation predicts nonradiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model. J. Nutr. 1998;128:1555-1561
7. Glahn R. P., Rassier M., Goldman M. I., Lee O. A., Cha J. A comparison of iron availability from commercial iron preparations using an in vitro digestion/Caco-2 cell culture model. J. Nutr. Biochem. 2000;11:62-68[Medline]
8. Glahn R. P., Wien E. M., Van Campen D. R., Miller D. D. Caco-2 cell iron uptake from meat and casein digests parallels in vivo studies: use of a novel in vitro method for rapid estimation of iron bioavailability. J. Nutr. 1996;126:332-339
9.
Au A. P., Reddy M. B. Caco-2 cells can be used to assess human iron bioavailability from a semipurified meal. J. Nutr. 2000;130:1329-1334
10. Tamura T., Stokstad E.L.R. The availability of food folate in man. Br. J. Haematol. 1973;25:513-532[Medline]
11.
Pfeiffer C. M., Rogers L. M., Bailey L. B., Gregory J. F., III Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. Am. J. Clin. Nutr. 1997;66:1388-1397
12. Buchholz B. A., Arjomand A., Dueker S. R., Schneider P. D., Clifford A. J., Vogel J. S. Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of 14C-labeled folic acid with accelerator mass spectrometry. Anal. Biochem. 1999;269:348-352[Medline]
This article has been cited by other articles:
![]() |
L. Martini and R. J Wood Relative bioavailability of calcium-rich dietary sources in the elderly Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1345 - 1350. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||